Malone-Lee J - Search Results

1

Autonomic side effects of Botulinum toxin Type B intravesical injections: report of 4 cases and review of the literature.

Ghei M, Maraj BH, Nathan S, Malone-Lee J, Miller R. Ghei M, et al. Int Urol Nephrol. 2006;38(3-4):543-4. doi: 10.1007/s11255-005-8681-1. Int Urol Nephrol. 2006. PMID: 17136583 Review.

2

A day case technique for administration of intradetrusor Botulinum toxin B under sedo-analgesia in neuropathic and non-neuropathic detrusor overactivity: Endoscopic Neurostabilisation (ENS).

Ghei M, Nathan S, Maraj BH, Malone-Lee JG, Miller R. Ghei M, et al. Int Urol Nephrol. 2005;37(3):471-2. doi: 10.1007/s11255-004-4736-y. Int Urol Nephrol. 2005. PMID: 16307321 No abstract available.

3

Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.

Ghei M, Maraj BH, Miller R, Nathan S, O'Sullivan C, Fowler CJ, Shah PJ, Malone-Lee J. Ghei M, et al. J Urol. 2005 Nov;174(5):1873-7; discussion 1877. doi: 10.1097/01.ju.0000177477.83991.88. J Urol. 2005. PMID: 16217327 Clinical Trial.

4

Case series data to encourage randomized trials of bladder retraining compared to antimuscarinic agents.

Ghei M, Miller R, Malone-Lee J. Ghei M, et al. J Urol. 2006 Apr;175(4):1411-5; discussion 1415-6. doi: 10.1016/S0022-5347(05)00705-6. J Urol. 2006. PMID: 16516010

5

Using the circumstances of symptom experience to assess the severity of urgency in the overactive bladder.

Ghei M, Malone-Lee J. Ghei M, et al. J Urol. 2005 Sep;174(3):972-6. doi: 10.1097/01.ju.0000170235.22776.1a. J Urol. 2005. PMID: 16094017

6

A simple validated scale to measure urgency.

Al-Buheissi S, Khasriya R, Maraj BH, Malone-Lee J. Al-Buheissi S, et al. J Urol. 2008 Mar;179(3):1000-5; discussion 1005. doi: 10.1016/j.juro.2007.10.075. Epub 2008 Jan 18. J Urol. 2008. PMID: 18206957

7

Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice.

Collins L, Sathiananthamoorthy S, Fader M, Malone-Lee J. Collins L, et al. Int Urogynecol J. 2017 Sep;28(9):1351-1356. doi: 10.1007/s00192-017-3271-1. Epub 2017 Jan 23. Int Urogynecol J. 2017. PMID: 28116467

8

Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.

Fader M, Glickman S, Haggar V, Barton R, Brooks R, Malone-Lee J. Fader M, et al. J Urol. 2007 Jan;177(1):208-13; discussion 213. doi: 10.1016/j.juro.2006.08.099. J Urol. 2007. PMID: 17162046 Clinical Trial.

9

The inadequacy of urinary dipstick and microscopy as surrogate markers of urinary tract infection in urological outpatients with lower urinary tract symptoms without acute frequency and dysuria.

Khasriya R, Khan S, Lunawat R, Bishara S, Bignall J, Malone-Lee M, Ishii H, O'Connor D, Kelsey M, Malone-Lee J. Khasriya R, et al. J Urol. 2010 May;183(5):1843-7. doi: 10.1016/j.juro.2010.01.008. Epub 2010 Mar 29. J Urol. 2010. PMID: 20303096

10

Characterisation of detrusor contractile function in relation to old age.

Malone-Lee J, Wahedna I. Malone-Lee J, et al. Br J Urol. 1993 Dec;72(6):873-80. doi: 10.1111/j.1464-410x.1993.tb16289.x. Br J Urol. 1993. PMID: 8306149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters